Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2563773rdf:typepubmed:Citationlld:pubmed
pubmed-article:2563773lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:2563773lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:2563773lifeskim:mentionsumls-concept:C0015846lld:lifeskim
pubmed-article:2563773lifeskim:mentionsumls-concept:C0031960lld:lifeskim
pubmed-article:2563773lifeskim:mentionsumls-concept:C1883695lld:lifeskim
pubmed-article:2563773lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:2563773lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:2563773lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:2563773lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:2563773lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:2563773pubmed:issue3lld:pubmed
pubmed-article:2563773pubmed:dateCreated1989-4-6lld:pubmed
pubmed-article:2563773pubmed:abstractTextA research program based on certain heterocyclic modifications (12-50) of the fentanyl (1) molecule has generated a novel class of opioids. In the mouse hot-plate test, these compounds were weaker analgesics than 1. Two types of antagonists were observed in morphine-treated rabbits: those (e.g., 28) that reversed both respiratory depression and analgesia and those (e.g. 32) that selectively reversed respiratory depression. Evaluation of in vitro binding affinities to rat brain opioid receptors was inconclusive for a common locus of action for the agonist as well as the antagonist component. Further pharmacological evaluation of 32, N-(2-pyrazinyl)-N-(1-phenethyl-4-piperidinyl)-2-furamide, in the rat showed it to be a potent analgesic (ED50 = 0.07 mg/kg, tail-flick test) with little cardiovascular and respiratory depression when compared to fentanyl.lld:pubmed
pubmed-article:2563773pubmed:languageenglld:pubmed
pubmed-article:2563773pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2563773pubmed:citationSubsetIMlld:pubmed
pubmed-article:2563773pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2563773pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2563773pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2563773pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2563773pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2563773pubmed:statusMEDLINElld:pubmed
pubmed-article:2563773pubmed:monthMarlld:pubmed
pubmed-article:2563773pubmed:issn0022-2623lld:pubmed
pubmed-article:2563773pubmed:authorpubmed-author:WynnR LRLlld:pubmed
pubmed-article:2563773pubmed:authorpubmed-author:BagleyJ RJRlld:pubmed
pubmed-article:2563773pubmed:authorpubmed-author:SpauldingTTlld:pubmed
pubmed-article:2563773pubmed:authorpubmed-author:RudoF GFGlld:pubmed
pubmed-article:2563773pubmed:authorpubmed-author:DoorleyB MBMlld:pubmed
pubmed-article:2563773pubmed:authorpubmed-author:SpencerH KHKlld:pubmed
pubmed-article:2563773pubmed:issnTypePrintlld:pubmed
pubmed-article:2563773pubmed:volume32lld:pubmed
pubmed-article:2563773pubmed:ownerNLMlld:pubmed
pubmed-article:2563773pubmed:authorsCompleteYlld:pubmed
pubmed-article:2563773pubmed:pagination663-71lld:pubmed
pubmed-article:2563773pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:meshHeadingpubmed-meshheading:2563773-...lld:pubmed
pubmed-article:2563773pubmed:year1989lld:pubmed
pubmed-article:2563773pubmed:articleTitleNew 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.lld:pubmed
pubmed-article:2563773pubmed:affiliationChemistry Groups, BOC Technical Center, Murray Hill, New Jersey 07974.lld:pubmed
pubmed-article:2563773pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2563773pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2563773lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2563773lld:pubmed